cancer immunotherapy and antibody treatment; osteosarcoma
2026 · 2nd Quarter (Apr 1 - June 30)
OS THERAPIES
Filed by CHAMBER HILL STRATEGIES.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 19, 2026
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- CHAMBER HILL STRATEGIES
- Client
- OS THERAPIES
- Filing UUID
- 71a3749e-4cdd-4b6f-8fc4-968a83e659e2
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
cancer immunotherapy and antibody treatment; osteosarcoma
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.